Overview Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003) Status: Completed Trial end date: 2009-03-01 Target enrollment: Participant gender: Summary This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic efficacy of MK0773 in healthy postmenopausal women. Phase: Phase 1 Details Lead Sponsor: Merck Sharp & Dohme Corp.